共 27 条
Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy
被引:142
作者:
Li, BSY
Wang, H
Gonen, O
机构:
[1] NYU, Sch Med, Dept Radiol, New York, NY 10016 USA
[2] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA
关键词:
brain;
metabolite concentration;
metabolite-ratio;
quantification;
proton MR spectroscopy (H-1-MRS);
D O I:
10.1016/S0730-725X(03)00181-4
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
In localized brain proton MR spectroscopy (H-1-MRS), metabolites' levels are often expressed as ratios, rather than as absolute concentrations. Frequently, their denominator is the creatine [Cr], which level is explicitly assumed to be stable in normal as well as in many pathologic states. The rationale is that ratios self-correct for imager and localization method differences, gain instabilities, regional susceptibility variations and partial volume effects. The implicit assumption is that these benefits are worth their cost(w)-(w) propagation of the individual variation of each of the ratio's components. To test this hypothesis, absolute levels of N-acetylaspartate [NAA], choline [Cho] and [Cr] were quantified in various regions of the brains of 8 volunteers, using 3-dimensional (3D) H-1-MRS at 1.5 T. The results show that in over 50% of similar to2000 voxels examined, [NAA]/[Cr] and [Cho]/[Cr] exhibited higher coefficients of variations (CV) than [NAA] and [Cho] individually. Furthermore, in similar to33% of these voxels, the ratios' CVs exceeded even the combined constituents' CVs. Consequently, basing metabolite quantification on ratios and assuming stable [Cr] introduces more variability into H-1-MRS than it prevents. Therefore, its cost exceeds the benefit. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:923 / 928
页数:6
相关论文